Colistin–Meropenem Synergy in Carbapenem Resistant Gram-Negative Infections: A Practical Clinical Guide
Episode Summary
Colistin-meropenem combination therapy may improve treatment of severe carbapenem-resistant infections, prompting closer monitoring, rapid diagnostics, and updated antibiotic stewardship strategies in critical care settings.